Here are relevant reports on : adult-diapers-market
-
Smart Diapers Market by End-Use (Babies, Adults), Technology (RFID Tags, Bluetooth Sensors), and Geography (North America, Asia Pacific, Europe, and Rest of World) (2022 - 2026)
The Smart diapers market is projected to reach USD 1,531 million by 2026, at a CAGR of 18.8 % during the forecast period. Some of the key players in the North American smart diapers market are Procter & Gamble (US), Kimberly-Clark (US), Vandrico Solutions Inc (Canada), ElderSens (US), and Smardii Inc. (US).
- Published: November 2021
- Price: $ 4950
- TOC Available:
-
Vitamin D Therapy Market by Route of administration (Oral, Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases) - Global Forecast to 2024
The vitamin D therapy market is projected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6% during the forecast period. Growth in this market is largely driven by the growing awareness about vitamin D deficiency and the presence of a large target patient population. On the other hand, the fortification of foods is likely to challenge the growth of this market. Some of the major players in this market include Abbott (US), Sanofi (France), GlaxoSmithKline plc (UK), Pfizer Inc. (US), Merck & Co., Inc. (US), Torrent Pharmaceuticals Ltd. (India), Novartis International AG (Switzerland), Alkem Laboratories (India), Sun Pharmaceutical Industries Ltd. (India), and Cadila Healthcare Ltd. (India).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Ventilators Market by Mobility (Intensive Care Ventilators, Transportable Ventilators), Type (Adult & Pediatric Ventilators), Interface (Hybrid Ventilation), Mode (Combined Mode Ventilation), Care Setting (Hospitals & Clinics) - Global Forecast to 2029
The global ventilators market, valued at US$3.86B in 2023, is forecasted to grow at a 4.7% CAGR, reaching US$3.71B by 2024 and US$4.66B by 2029. The demand for invasive and non-invasive ventilator systems has increased due to the rapidly growing geriatric population and the increasing rates of respiratory diseases such as pneumonia, ARDS, and COPD.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Bunion Surgery Market by Product (Correction Systems, Implants & Accessories), Patient Type (Adult, Pediatric), Type (Minimally Invasive Surgery, Traditional Surgery), End User (Hospitals, ASCs, Orthopedic Clinics), Region - Global Forecast to 2029
The global bunion surgery market, valued at US$437.8 million in 2023, stood at US$458.4 million in 2024 and is projected to advance at a resilient CAGR of 5.7% from 2024 to 2029, culminating in a forecasted valuation of US$606.1 million by the end of the period. The main factor driving this market is the rising prevalence of bunions, which has led to an increased demand for surgical treatments.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Resuscitation Devices Market by Product (Defibrillator, Endotracheal & Tracheostomy Tube, Masks, Airways, Laryngoscopes, Resuscitators, Ventilators), Patient Type (Neonatal, Adult), End User (Hospital, Ambulance, ICU), Volume & Region - Global Forecasts to 2025
The global resuscitation devices market in terms of revenue was estimated to be worth $6.9 billion in 2020 and is poised to reach $8.7 billion by 2025, growing at a CAGR of 4.7% from 2020 to 2025. Prominent players in this market includes Koninklijke Philips N.V. (Netherlands), Medtronic plc (Ireland), ZOLL Medical Corporation (US), ResMed Inc. (US), Physio-Control (acquired by Stryker Corporation) (US), Drägerwerk AG & Co. KGaA (Germany), Smiths Medical (US), Ambu (Denmark), Cardinal Health (US), Mindray Medical (China), Nihon Kohden (Japan), Teleflex (US), Salter Labs (US), GE Healthcare (US), Roper Technologies (US), Vyaire Medical (US), Intersurgical (UK), 3M (US), Flexicare (UK), and KARL STORZ (Germany).
- Published: March 2020
- Price: $ 4950
- TOC Available:
-
CAR T-cell Therapy Market by Product (Abecma, Breyanzi, Carvykti, Yescarta, Tecartus, Kymriah), Target Antigen (CD19, BCMA), Indication (Multiple Myeloma, Leukemia, Lymphoma), Demographic (Adult, Pediatric), End User & Region - Global Forecast to 2029
The global CAR T-cell therapy market, valued at US$3.7 billion in 2023, stood at US$5.5 billion in 2024 and is projected to advance at a resilient CAGR of 39.6% from 2024 to 2029, culminating in a forecasted valuation of US$29.0 billion by the end of the period. The growth of this market due to the rise in investments and funding for CAR T-cell therapy developments and technological advancements in CAR T-cell therapy.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Compounding Pharmacy Market by Product (Oral, Topical, Parenteral), Compounding Type (Ingredient Alteration, Dosage Alteration), Therapeutic Application (Pain Management, HRT), Sterility (Sterile), End User (Pediatric, Adult) - Global forecast to 2030
The global Compounding Pharmacy market, valued at US$13.48 billion in 2024, stood at US$14.72 billion in 2025 and is projected to advance at a resilient CAGR of 5.7% from 2025 to 2030, culminating in a forecasted valuation of US$19.41 billion by the end of the period.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
US Telehealth & Telemedicine Market by Function (Clinical Care, Teleconsult, RPM, Patient Engagement, Analytics), Application (TeleICU, Teleradiology, Telecardiology, Diabetes), Age (Adult, Pediatric), End User (Hospital, Payer, ASC) - Forecast to 2030
The US telehealth & telemedicine market is projected to reach USD 83.63 billion by 2030 from USD 51.40 billion in 2025, at a high CAGR of 10.2% during the forecast period. The Key Players Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), Teladoc Health, Inc. (US), Cisco Systems, Inc. (US), Zoom Communications, Inc. (US), Doximity, Inc. (US), GE Healthcare (US), American Well (US), Siemens Healthineers AG (Germany), Epic Systems Corporation, Included Health, Inc. (US), AMC Health (US), TeleSpecialists (US), Walgreen Co. (US), Caregility (US), CVS Health (US), Evernorth Health, Inc. (US), Elation (US), Iron Bow Technologies (US), Oracle (US).
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Pulse Oximeter Market by Product (Equipment, Sensor), Type [Portable (Handheld, Wearable, Fingertip), Bedside], Technology (Conventional, Connected), Age Group (Adult, Infant, Neonatal), End User (Hospitals, Home Care), Region - Global Forecast to 2032
The global pulse oximeter market, valued at US$3.59 billion in 2024, stood at US$3.92 billion in 2025 and is projected to advance at a resilient CAGR of 8.7% from 2025 to 2032, culminating in a forecasted valuation of US$7.03 billion by the end of the period. The growth of this market is primarily driven by the rising prevalence of respiratory diseases, increasing prevalence of congenital heart disease (CHD) in children, a growing number of surgical procedures and hospitalizations, an increasing geriatric population, and subsequent rise in chronic diseases, technological advancements in pulse oximeter devices, growing investments in healthcare infrastructure, and the outbreak of infectious respiratory diseases.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Gummy Vitamins Market by Product Type (Multivitamins, Single Vitamins), Source (Animal, Plant), Packaging Type (Bottles & Jars, Pouches), Distribution Channel (Store-Based, Online), End User (Adult, Children), and Region - Global Forecast to 2025
According to MarketsandMarkets, the global gummy vitamins market is projected to reach USD 10.6 billion by 2025, recording a CAGR of 12.5% during the forecasting period. This report includes a study on the marketing and development strategies, along with the product portfolios of leading companies. It consists of profiles of leading companies, such as Church & Dwight Co. Inc. (US), Life Science Nutritionals (Canada), Bettera Brands LLC (US), Softigel (US), Nature's Way Products, LLC (US), Zanon Vitamec Inc. (US), Olly Public Benefit Corporation (US), Herbaland Naturals Inc. (Canada), Hero Nutritionals, LLC (US), SmartyPants Inc. (US), The Nature's Bounty Co. (US), IM Healthcare (India), Nutra Solutions (US), Makers Nutrition, LLC (US), Vitakem Nutraceutical Inc. (US), Bayer Group (Germany), The Clorox Company (US), Ernest Jackson (UK), Boscogen, Inc (US), and Santa Cruz Nutritionals Inc. (US).
- Published: October 2020
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
